Work

Abstract C160: Baseline characteristics, safety, and efficacy of Radium-223 in metastatic castration resistant prostate cancer by race: Insights from the REASSURE US subset

Year: 2024

Type: conference-abstract

Source: Cancer Epidemiology Biomarkers & Prevention

DOI: 10.1158/1538-7755.disp24-c160

Authors: Peter S. Conti, Oliver Sartor, Mary-Ellen Taplin, Daniel Y. Song, Saby George, Jeffrey Tomaszewski, John Sylvester, Constantine Mantz, Robert W. Given, Robert Brookland, Jeff Meltzer, Matthew J. Korn, Richard Andres, Svetlana Babajanyan, Celestia Higano

Institutions: University of Southern California, USC Norris Comprehensive Cancer Center, Tulane University, Dana-Farber Cancer Institute, Johns Hopkins University, Johns Hopkins Medicine, Roswell Park Comprehensive Cancer Center, Cooper University Hospital, Eastern Virginia Medical School, Chesapeake Urology Associates, Bayer (United States), University of Washington, Fred Hutch Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4402708864

Cites:

Cited by:

Related to: 10